Table 1.

Classification of incident hematologic malignancies

Disease	Cases n (%)
Myeloid Neoplasms	138 (23.5%)
Myelodysplastic Syndromes (MDS)	55 (9.4%)
Acute Myeloid Leukemia (AML)	36 (6.1%)
Myeloproliferative Neoplasms*	47 (8.0%)
Mature B-cell Neoplasms	396 (67.3%)
Chronic Lymphocytic Leukemia (CLL/SLL)	91 (15.5%)
Plasma Cell Disorders	67 (11.4%)
Other Mature B-cell Neoplasm Entities	238 (40.5%)
Hodgkin Lymphoma	23 (3.9%)
Mature T- and NK-Cell Neoplasms	17 (2.9%)
Others**	14 (2.4%)
Total	588 (100%)

^*Includes the diagnostic category of myelodysplastic/myeloproliferative neoplasms.

^**Includes cases of malignant lymphoma, not otherwise specified [NOS]; leukemia, NOS; acute biphenotypic leukemia; and precursor B-cell lymphoblastic leukemia.